tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Aardvark Therapeutics doses first patient in HERO trial
PremiumThe FlyAardvark Therapeutics doses first patient in HERO trial
6d ago
Closing Bell Movers: Marvell up 11%, reversing initial earnings selloff
Premium
The Fly
Closing Bell Movers: Marvell up 11%, reversing initial earnings selloff
14d ago
Aardvark Therapeutics up 9% at $10.10 after Raymond James Strong Buy initiation
Premium
The Fly
Aardvark Therapeutics up 9% at $10.10 after Raymond James Strong Buy initiation
14d ago
Aardvark Therapeutics, Inc.: Undervalued Potential in the Obesity Treatment Market with Promising Pipeline
PremiumRatingsAardvark Therapeutics, Inc.: Undervalued Potential in the Obesity Treatment Market with Promising Pipeline
1M ago
Datadog, Trade Desk upgraded: Wall Street’s top analyst calls
Premium
The Fly
Datadog, Trade Desk upgraded: Wall Street’s top analyst calls
1M ago
Aardvark Therapeutics initiated with a Buy at BTIG
Premium
The Fly
Aardvark Therapeutics initiated with a Buy at BTIG
1M ago
Aardvark Therapeutics Advances PWS Treatment with ARD-101 Study
PremiumCompany AnnouncementsAardvark Therapeutics Advances PWS Treatment with ARD-101 Study
2M ago
Aardvark Therapeutics’ ARD-101 Study: A New Hope for Prader-Willi Syndrome
Premium
Company Announcements
Aardvark Therapeutics’ ARD-101 Study: A New Hope for Prader-Willi Syndrome
2M ago
Aardvark Therapeutics Aligns with FDA on Trial Amendment
Premium
Company Announcements
Aardvark Therapeutics Aligns with FDA on Trial Amendment
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100